WEE1 Inhibitor AZD1775, External Beam Radiation Therapy, and Cisplatin in Treating Patients With Cervical, Vaginal, or Uterine Cancer

Conditions:   Endometrioid Adenocarcinoma;   Recurrent Cervical Carcinoma;   Stage I Uterine Corpus Cancer;   Stage I Vaginal Cancer;   Stage IA Uterine Corpus Cancer;   Stage IB Cervical Cancer;   Stage IB Uterine Corpus Cancer;   Stage II Cervical Cancer;   Stage II Uterine  Corpus Cancer;   Stage II Vaginal Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Cervical Cancer;   Stage III Uterine Corpus Cancer;   Stage III Vaginal Cancer;   Stage IIIA Cervical Cancer;   Stage IIIA Uterine Corpus Cancer;   St age IIIB Cervical Cancer;   Stage IIIB Uterine Corpus Cancer;   Stage IIIC Uterine Corpus Cancer Interventions:   Drug: Cisplatin;   Radiation: External Beam Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: WEE1 Inhibitor AZD1775 Sponsor:   National Cancer Institute (NCI) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials